Martin Stahl
Directeur/Membre du Conseil chez The Cambridge Crystallographic Data Centre
Provenance du réseau au premier degré de Martin Stahl
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
The Cambridge Crystallographic Data Centre
 The Cambridge Crystallographic Data Centre Data Processing ServicesTechnology Services The Cambridge Crystallographic Data Centre, founded in 1965, is a non-profit company that specializes in providing support and licensing for their CSD data and software. The company is based in Cambridge, UK and has subsidiaries in the United Kingdom. The British company's historical structures date back to the 1920s. The CS-Crossminer software allows users to build pharmacophore queries and mine the CS data simultaneously.
6
| Non-Profit Organization | Data Processing Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Martin Stahl via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EXSCIENTIA PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Medicines Discovery Catapult Ltd.
 Medicines Discovery Catapult Ltd. Miscellaneous Commercial ServicesCommercial Services Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| University of Bath | College/University | Undergraduate Degree | |
| Birkbeck University of London | College/University | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 6 |
| Etats-Unis | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| John Overington | 7 |
| Paul Raithby | 1 |
| Judith Currano | 1 |
| John Pyle | 1 |
| David Martinsen | 1 |
| Alessia Bacchi | 1 |
- Bourse
- Insiders
- Martin Stahl
- Connexions Sociétés
